Assembly Biosciences Inc (NASDAQ:ASMB)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ASMB

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ASMB

  • Market Cap$477.710m
  • SymbolNASDAQ:ASMB
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS0453961080

Company Profile

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.

Latest ASMB news

Currently there for this company. Visit our news hub for other news .